Raymond James & Associates’s PLDT PHI Stock Holding History
Bought
Maintained
Sold
Other funds holding PHI
MIP
VLKIM
BSPF
Raymond James & Associates's PHI Position: Q2 2016 in Review
Raymond James & Associates sold out of PLDT (PHI) in Q2 2016, closing a stake of 10,934 shares — an estimated $474K sold.
Raymond James & Associates first reported a position in PHI in Q2 2013 and held it in 10 quarters. The position peaked at $8.66M in Q3 2014. 78 funds tracked by Wall St. Rank hold PHI as of Q2 2016.
- Raymond James & Associates reported no remaining PLDT position as of Q2 2016 after selling out during the quarter.
- Raymond James & Associates sold 10,934 PLDT shares in Q2 2016, an estimated $474K.
- Raymond James & Associates first reported a position in PLDT in Q2 2013 and held it in 10 quarters.
- Raymond James & Associates's PLDT position peaked at $8.66M in Q3 2014.
- 78 funds tracked by Wall St. Rank held PLDT as of Q2 2016.
Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.